Recent Price Trend in NCS Multistage (NCSM) is Your Friend, Here's Why
ZACKS· 2025-09-19 13:51
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done.The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the st ...
Norsk Hydro ASA (NHYDY) Is Attractively Priced Despite Fast-paced Momentum
ZACKS· 2025-09-19 13:51
Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time.Everyone likes betting on fast-moving trending stocks, but it isn't easy to determine the right entry point. These stocks often lose momentum when their future growth potenti ...
Fast-paced Momentum Stock Macy's (M) Is Still Trading at a Bargain
ZACKS· 2025-09-19 13:51
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time.Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead of their future growth potential. In such a situation, invest ...
Fast-paced Momentum Stock Kohl's (KSS) Is Still Trading at a Bargain
ZACKS· 2025-09-19 13:51
Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point, as stocks may lose momentum when their valuations exceed future growth potential [2] - A safer approach involves investing in bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify such opportunities [3] Group 2: Kohl's (KSS) Stock Analysis - Kohl's (KSS) has shown significant recent price momentum, with a four-week price change of 30.5%, indicating growing investor interest [4] - Over the past 12 weeks, KSS has gained 108.6%, demonstrating its ability to deliver positive returns over a longer timeframe [5] - KSS has a high beta of 1.74, suggesting it moves 74% more than the market in either direction, indicating fast-paced momentum [5] - The stock has a Momentum Score of A, suggesting it is an opportune time to invest in KSS to capitalize on its momentum [6] Group 3: Earnings Estimates and Valuation - KSS has received upward revisions in earnings estimates, earning a Zacks Rank 2 (Buy), which is associated with strong momentum effects [7] - The stock is currently trading at a Price-to-Sales ratio of 0.12, indicating it is attractively priced at only 12 cents for each dollar of sales, providing ample room for growth [7] Group 4: Additional Investment Opportunities - Besides KSS, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting further investment opportunities [8] - The Zacks Premium Screens offer over 45 different strategies tailored to help investors find winning stock picks [9]
Kiniksa Pharmaceuticals International, plc (KNSA) is on the Move, Here's Why the Trend Could be Sustainable
ZACKS· 2025-09-19 13:51
Core Viewpoint - The article emphasizes the importance of identifying and sustaining trends in short-term investing, highlighting that sound fundamentals and positive earnings estimates are crucial for maintaining momentum in stock prices [1]. Group 1: Investment Strategy - Investors can utilize the "Recent Price Strength" screen to identify stocks that are trending upwards, supported by strong fundamentals and trading near their 52-week high [2]. - Kiniksa Pharmaceuticals International, plc (KNSA) is highlighted as a strong candidate for trend investors, having increased by 26.1% over the past 12 weeks, indicating investor confidence in its potential [3]. - A recent price increase of 7% over the last four weeks suggests that KNSA's upward trend is still intact, and it is currently trading at 92.7% of its 52-week high-low range, indicating a potential breakout [4]. Group 2: Fundamental Analysis - KNSA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, which are critical for short-term price movements [5]. - The Zacks Rank system has a strong historical performance, with Rank 1 stocks averaging a +25% annual return since 1988, reinforcing the potential for KNSA's continued success [6]. - The Average Broker Recommendation for KNSA is also 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [6]. Group 3: Additional Opportunities - Besides KNSA, there are other stocks that meet the criteria of the "Recent Price Strength" screen, suggesting a broader opportunity for investors to explore [7]. - The article encourages investors to consider various Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [7].
SoftBank is preparing for global layoffs to its Vision Fund team, in a pivot to AI
Fastcompany· 2025-09-19 13:51
SoftBank Group will lay off nearly 20% of its Vision Fund team globally as it shifts resources to founder Masayoshi Son's large-scale artificial intelligence bets in the United States, according to a ... ...
Is Oklo Inc (OKLO) The Best AI Energy Stock to Buy Now?
Yahoo Finance· 2025-09-19 13:50
We recently published Top 10 Stocks to Watch After Federal Reserve’s Rate Cut. Oklo Inc (NYSE:OKLO) is one of the stocks analysts were recently talking about. Dimple Gosai, Bank of America clean energy analyst, explained in a program on CNBC why she’s bullish on Oklo Inc (NYSE:OKLO). She has a Buy rating and $92 price target on the stock. “I think the one thing that we really need to um unpack here is where the end demand is coming from. So, today if you think about electricity demand, we think that t ...
US stocks continue rally at open: S&P climbs 0.3%, Dow up 0.2%
Invezz· 2025-09-19 13:50
Stocks rose Friday, building on a winning session that pushed indexes to fresh records after the Federal Reserve's interest rate cut boosted investor confidence. The Dow Jones Industrial Average added 98 points, or 0.2 percent. ...
Analyst Says Tesla (TSLA) Auto Business ‘Continues to Worsen’
Yahoo Finance· 2025-09-19 13:50
We recently published Top 10 Stocks to Watch After Federal Reserve’s Rate Cut. Tesla, Inc. (NASDAQ:TSLA) is one of the stocks analysts were recently talking about. In late July, Jed Dorsheimer, a William Blair analyst, said in a program on CNBC that Tesla’s deal with Samsung for chip production was positive and showed a “data point” that Elon Musk is innovating. However, the analyst explained why he downgraded the stock: “The reason for our downgrade was the auto business continues to worsen. And yes, it ...
Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: 6-DAY DEADLINE in Securities Lawsuit – Hagens Berman
Globenewswire· 2025-09-19 13:50
Group 1 - A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action, allowing new investors to apply by September 24, 2025 [1][2] - The class period for the lawsuit is from March 17, 2022, to September 22, 2022, and the case has survived a motion to dismiss [3][4] - The lawsuit alleges that Spectrum misled investors about the success of its cancer treatment drug, poziotinib, leading to a share price drop of over 37% when FDA concerns were revealed [3][4] Group 2 - Assertio Holdings (ASRT) acquired Spectrum Pharmaceuticals in July 2023, allowing investors who received ASRT shares after acquiring SPPI shares during the class period to potentially represent the class [5] - Hagens Berman is encouraging investors who suffered significant losses to consider becoming the new lead plaintiff, emphasizing the importance of this role in overseeing litigation [6]